Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Abbott Laboratories (ABT) Stock-Based Compensation data is not available for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$13.01B |
|
$920.00M |
|
$5.63B |
|
$7.38B |
|
$11.65B |
|
$1.36B |
|
$-127.00M |
|
$1.23B |
|
$1.23B |
|
$920.00M |
|
$920.00M |
|
$920.00M |
|
$920.00M |
|
$1.36B |
|
-- |
|
-- |
|
1.74B |
|
-- |
|
$0.53 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|